Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

NCT06758713 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma
B-cell Lymphoma
Hematological Malignancy

Interventions

BIOLOGICAL: CAR-T

Sponsor

The Third Affiliated Hospital of Southern Medical University